Full-Time

Cyber and 3rd party risk manager

Confirmed live in the last 24 hours

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

No salary listed

Mid, Senior

Hyderabad, Telangana, India

Category
Cybersecurity
IT & Security
Required Skills
Risk Management
Connection
Connection
Connection
logo

Get referrals →

You have ways to get a Amgen referral from your network.

💡

Applications through a referral are 3x more likely to get an interview!

Requirements
  • Bachelor’s degree in information technology, Cybersecurity, Risk Management, or a related field.
  • Certifications such as CRISC (Certified in Risk and Information Systems Control), CISA (Certified Information Systems Auditor), or CISSP (Certified Information Systems Security Professional) are highly desirable.
  • 4-6 years of experience in IT risk management, IT auditing, or information security.
  • Hands-on experience with risk management tools and frameworks (e.g., ISO 27001, NIST, COBIT).
  • Strong understanding of IT infrastructure, systems, and security best practices.
  • Ability to assess technical and business risk related to information systems.
  • Excellent problem-solving, analytical, and communication skills.
  • Ability to communicate complex risk concepts to non-technical stakeholders.
  • Ability to assess and interpret security-related clauses in third-party contracts, such as Security Requirements Schedules (SRS).
  • Familiarity with regulatory frameworks and compliance standards (e.g., GDPR, HIPAA, SOX, PCI-DSS).
  • Proficiency with risk management tools, GRC (Governance, Risk, and Compliance) software, and security incident management tools.
  • Experience with security controls related to networks, databases, and cloud environments.
Responsibilities
  • Support the global risk management and third-party organization in leading a team of risk analysts performing tasks related to the global risk assessment processes.
  • Conduct risk assessments to identify vulnerabilities in IT systems, processes, and policies.
  • Assist in the identification and evaluation of risks associated with third-party vendors and partners.
  • Maintain the IT risk register, documenting risks, issues, and remediation actions.
  • Recommend risk mitigation strategies and implement risk management controls across IT infrastructure.
  • Collaborate with IT, cybersecurity, and business teams to track and resolve identified risks and vulnerabilities.
  • Monitor and report on the effectiveness of existing IT risk controls and recommend enhancements as needed.
  • Ensure compliance with relevant industry standards and regulatory requirements (e.g., GDPR, SOX, PCI-DSS, NIST).
  • Assist in the preparation for audits by internal and external parties, providing documentation and evidence of IT risk management practices.
  • Support the development and implementation of IT governance, risk, and compliance frameworks.
  • Conduct vendor risk assessments, ensuring third-party services and products align with internal risk and security policies.
  • Regularly review vendor performance and risk exposure, working with procurement and legal teams as necessary.
Desired Qualifications
  • Certifications such as CRISC (Certified in Risk and Information Systems Control), CISA (Certified Information Systems Auditor), or CISSP (Certified Information Systems Security Professional) are highly desirable.

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are medicines made from living organisms. These therapies target conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen stands out from competitors by reinvesting a large portion of its earnings into research and development, ensuring a strong pipeline of new treatments. The goal of Amgen is to improve patient care and address critical health challenges through its innovative therapeutic solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Amgen's investment in AI aligns with trends in biotechnology innovation.
  • Institutional investments indicate strong market confidence in Amgen's growth.
  • FTC clearance of the Horizon merger may ease future regulatory hurdles.

What critics are saying

  • Competitors' AI-driven drug discovery could outpace Amgen's traditional R&D methods.
  • FTC scrutiny of mergers may complicate Amgen's future growth strategy.
  • Advancements in quantum technologies could pose a competitive threat to Amgen.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline of potential new therapies in development.
  • Amgen's acquisition of Horizon Therapeutics enhances its rare disease portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.

BioSpace
Sep 19th, 2023
Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans

The consent agreement struck between the FTC and Amgen and Horizon Therapeutics could have significant implications for ongoing and future M&A challenges, experts told BioSpace.